| Literature DB >> 33767447 |
Erik Volz1, Swapnil Mishra2, Meera Chand3, Jeffrey C Barrett4, Robert Johnson2, Axel Gandy5, Andrew Rambaut6, Neil M Ferguson7, Lily Geidelberg2, Wes R Hinsley2, Daniel J Laydon2, Gavin Dabrera3, Áine O'Toole6, Robert Amato4, Manon Ragonnet-Cronin2, Ian Harrison3, Ben Jackson6, Cristina V Ariani4, Olivia Boyd2, Nicholas J Loman3,8, John T McCrone6, Sónia Gonçalves4, David Jorgensen2, Richard Myers3, Verity Hill6, David K Jackson4, Katy Gaythorpe2, Natalie Groves3, John Sillitoe4, Dominic P Kwiatkowski4, Seth Flaxman5, Oliver Ratmann5, Samir Bhatt2,9, Susan Hopkins3.
Abstract
The SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public Health England1, was first identified in the UK in late summer to early autumn 20202. Whole-genome SARS-CoV-2 sequence data collected from community-based diagnostic testing for COVID-19 show an extremely rapid expansion of the B.1.1.7 lineage during autumn 2020, suggesting that it has a selective advantage. Here we show that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S gene target failures (SGTF) in community-based diagnostic PCR testing. Analysis of trends in SGTF and non-SGTF case numbers in local areas across England shows that B.1.1.7 has higher transmissibility than non-VOC lineages, even if it has a different latent period or generation time. The SGTF data indicate a transient shift in the age composition of reported cases, with cases of B.1.1.7 including a larger share of under 20-year-olds than non-VOC cases. We estimated time-varying reproduction numbers for B.1.1.7 and co-circulating lineages using SGTF and genomic data. The best-supported models did not indicate a substantial difference in VOC transmissibility among different age groups, but all analyses agreed that B.1.1.7 has a substantial transmission advantage over other lineages, with a 50% to 100% higher reproduction number.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33767447 DOI: 10.1038/s41586-021-03470-x
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962